Enroll in LymphBridge™ Clinical Study

Prospective Evaluation of the BioBridge Scaffold as an Adjunct to Lymph Node Transplant for Upper Extremety Lymphedema

Now Enrolling 

LymphBridge™ Clinical Study screener

Eligibility requirements include:

  • Ages 28 to 75 years
  • Breast cancer survivor, have completed at least 3 years of cancer therapy, no evidence clinical disease and eligible for surgical intervention.
  • Acquired upper limb lymphedema secondary to breast cancer treatment
  • Stage I-II lymphedema at screening (ISL)
  • Willingness and ability to comply with recommend regimen and to comply with all study procedures and follow-up appointments
  • Limb volume in affected limb and unaffected limb must be at least 10% of each other
  • Body Mass Index (BMI) <35

Lymphbridge Clinical Study Interest

15 + 4 =